3,4-dihydroxyphenylacetic acid has been researched along with cytarabine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dalia, A; Hadjiconstantinou, M; Neff, NH | 1 |
Ikarashi, Y; Ishimaru, H; Kishi, E; Maruyama, Y; Takahashi, A | 1 |
Brown, PL; Cadet, JL; Elmer, GI; Greenwald, M; Krasnova, IN; Mayo, CL; McFarland, R; Schoonover, C; Shepard, PD; Stockman, S; Vogel, MW | 1 |
3 other study(ies) available for 3,4-dihydroxyphenylacetic acid and cytarabine
Article | Year |
---|---|
GM1 ganglioside improves dopaminergic markers of rat mesencephalic cultures treated with MPP+.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Aromatic-L-Amino-Acid Decarboxylases; Cells, Cultured; Cytarabine; Dopamine; G(M1) Ganglioside; Gestational Age; Immunohistochemistry; Kinetics; Mesencephalon; Neuroglia; Neurons; Neurotoxins; Rats; Rats, Sprague-Dawley; Time Factors; Tyrosine 3-Monooxygenase | 1993 |
Development of obesity and neurochemical backing in aurothioglucose-treated mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Animals; Antineoplastic Combined Chemotherapy Protocols; Antirheumatic Agents; Aurothioglucose; Brain Chemistry; Cytarabine; Daunorubicin; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mercaptopurine; Mice; Norepinephrine; Obesity; Paraventricular Hypothalamic Nucleus; Prednisolone; Proto-Oncogene Proteins c-fos; Serotonin; Solitary Nucleus; Ventromedial Hypothalamic Nucleus; Vincristine | 2001 |
Altered spatial learning, cortical plasticity and hippocampal anatomy in a neurodevelopmental model of schizophrenia-related endophenotypes.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cytarabine; Disease Models, Animal; Dopamine; Endophenotypes; Hippocampus; Male; Maze Learning; Neurogenesis; Neuronal Plasticity; Norepinephrine; Rats; Rats, Sprague-Dawley; Schizophrenia; Serotonin | 2012 |